Efficacy and Safety of Anti-CGRP Monoclonal Antibodies for Migraine Preventative Treatment

被引：0
|
作者：
Salim, Amira [1 ]
Najjar, Atia [1 ]
Ahmed, Zubair [1 ]
Mata, Ignacio [1 ]
机构：
[1] Cleveland Clin, Cleveland, OH USA
来源：
NEUROLOGY | 2023年 / 100卷 / 17期
关键词：
D O I：
10.1212/WNL.0000000000203826
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P6-12.011
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Anti-CGRP monoclonal antibodies: migraine prevention in patients with psychiatric comorbidities
    di Cola, Francesca Schiano
    Ceccardi, Giulia
    Caratozzolo, Salvatore
    Bolchini, Marco
    Di Pasquale, Michele
    Rao, Renata
    Padovani, Alessandro
    CEPHALALGIA, 2023, 43 (1supp) : 252 - 253
  • [32] ANTI-CGRP MONOCLONAL ANTIBODIES FOR NEUROPATHIC PAIN IN PATIENTS WITH MIGRAINE HEADACHE
    Kang, Seung Ah
    Govindarajan, Raghav
    MUSCLE & NERVE, 2020, 62 : S7 - S7
  • [33] Anti-CGRP Monoclonal Antibodies for Neuropathic Pain in Patients with Migraine Headache
    Kang, Seung Ah
    Govindarajan, Raghav
    NEUROLOGY, 2021, 96 (15)
  • [34] Effectiveness of anti-CGRP monoclonal antibodies in the preventive treatment of migraine: A prospective study of 63 patients
    Castrillo, Ana
    Mendoza, Amelia
    Caballero, Lorena
    Cerdan, Debora
    Rodriguez, Maria Fernanda
    Guerrero, Pilar
    Tabernero, Cesar
    Ferrero, Marta
    Benito, Ines
    Marin, Laura
    Duarte, Jacinto
    MEDICINA CLINICA, 2023, 160 (08): : 341 - 346
  • [35] OnabotulinumtoxinA Add-On to Monoclonal Anti-CGRP Antibodies in Treatment-Refractory Chronic Migraine
    Argyriou, Andreas A. A.
    Dermitzakis, Emmanouil V. V.
    Xiromerisiou, Georgia
    Vikelis, Michail
    TOXINS, 2022, 14 (12)
  • [36] OnabotulinumtoxinA add-on to monoclonal anti-CGRP antibodies in treatment-refractory chronic migraine
    Dermitzakis, E.
    Argyriou, A.
    Xiromerisiou, G.
    Vikelis, M.
    JOURNAL OF HEADACHE AND PAIN, 2024, 25
  • [37] Efficacy and tolerability of anti-CGRP monoclonal antibodies in patients aged=65 years with episodic or chronic migraine
    Biswas, Sudipa
    Salim, Amira
    Hennessy, Elise
    Suneja, Aarushi
    Ahmed, Zubair
    Mata, Ignacio
    NEUROLOGY, 2023, 100 (17)
  • [38] Effectiveness and safety of anti-CGRP monoclonal antibodies for migraine in patients over 65 years: a systematic review
    Munoz-Vendrell, Albert
    Lopez-Bravo, Alba
    Layos-Romero, Almudena
    Alberola-Amores, Francisco J.
    Caballero, Maria Obdulia Lozano
    Sanchez-Soblechero, Antonio
    Morales-Hernandez, Cristian
    Castro-Sanchez, Maria Victoria
    Navarro-Perez, Maria Pilar
    Cordova-Infantes, Maria Rocio
    Caronna, Edoardo
    Irimia, Pablo
    Gonzalez-Martinez, Alicia
    Jr Headache Grp Spanish Soc Neurology jGECSEN
    PAIN MANAGEMENT, 2025, 15 (03) : 161 - 171
  • [39] Future prophylactic treatments in migraine: Beyond anti-CGRP monoclonal antibodies and gepants
    Do, T. P.
    Al-Saoudi, A.
    Ashina, M.
    REVUE NEUROLOGIQUE, 2021, 177 (07) : 827 - 833
  • [40] Placebo effects in clinical trials of anti-CGRP monoclonal antibodies for migraine prevention
    Regnier, S.
    Lee, X. Ying
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1):
12345